Diabetes & Endocrinology Perspective

• Tirzepatide: 'Exciting' and Promising in Lowering A1c   Tirzepatide is the newest player in the quest for lowering A1c in people with type 2 diabetes. Dr Anne Peters describes the novel agent -- what it can do for patients now and in the future.
  Medscape Diabetes & Endocrinology, May 23, 2022
• Best & Worst Places to Practice 2022 Some states offer lots of perks and temptations for physician practices, although each doctor has their own priorities that make some places more desirable.
  Medscape Features Slideshows, May 20, 2022
• How Medicine Is Failing a Nation in Pain   Pain is central to every specialty, and we all played a part in the opioid crisis, says Dr Haider Warraich, author of The Song of Our Scars: The Untold Story of Pain.
  Medscape, May 20, 2022
• Environmental Health Is Going to Get Very Personal Sometimes it seems that not much can be done to protect the environment, but there are steps we can take to lessen the impact on our personal health and protect that of our patients.
  Endocrine Society, May 19, 2022
• A1c, Blood Pressure Fluctuations Predict Fracture Risk Dr Plotzker reviews new studies linking glycemic control and blood pressure variations to fractures in older populations.
  Medscape Diabetes & Endocrinology, May 18, 2022
• Episode 4: Better Ways to Sustain Weight Loss in Type 2 Diabetes   Patients with type 2 diabetes and obesity have more options today than ever before. Join host Dr Silvio Inzucchi and obesity expert Dr Ania Jastreboff as they discuss ways to support weight loss.
  Medscape, May 18, 2022
• Combating Stress and Tackling Cortisol With increasing stressors, controlling the stress hormone cortisol is more vital than before. Dr Guttenberg offers insight into the body's response to stress and tips on how to combat it.
  Endocrine Society, May 17, 2022
• Does COVID-19 Raise the Risk for Diabetes?   Is COVID-19 responsible for new-onset diabetes? Or are COVID infections bringing to light previously undiagnosed cases? Dr Anne Peters reviews recent studies around COVID and diabetes.
  Medscape Diabetes & Endocrinology, May 17, 2022
• Medscape Endocrinologist Compensation Report 2022 Medscape's Endocrinologist Compensation Report 2022 explores income sources, pay gaps, and attitudes about work as COVID's impact on medical practices declines.
  Medscape Features Slideshows, May 13, 2022
• Attending ASCO in Person This Year? Remember These 14 Tips Bishal Gyawali, MD, PhD, provides guidance on how to get the most out of the upcoming ASCO meeting.
  Medscape Oncology, May 12, 2022
• Anorexia Nervosa in Adolescent Patients: What You Need to Know Here we will review the epidemiology, diagnosis, and treatment of anorexia, with an emphasis on what pediatricians need to know to screen and to facilitate treatment.
  Medscape Pediatrics, May 12, 2022
• The Case for Post-COVID Steroids   Dr F. Perry Wilson cautions against changing practice on the basis of a single study.
  Medscape, May 12, 2022
• Sleep More, Weigh Less? Dr Aaron Holley looks at the current association of weight gain with sleep deprivation.
  Medscape Critical Care, May 10, 2022
• Why Iodized Salt Is Important for You and Your Thyroid Lack of iodine can lead to thyroid deficiency disorders. Dr Elizabeth Pearce discusses iodized salt, its importance, and how to increase iodine intake.
  Endocrine Society, May 10, 2022
• Young Adult Obesity Has Quintupled. Will 'Cancer Wave' Follow?   Maurie Markman discusses a recent article highlighting obesity prevalence among young adults with an eye toward the implications for cancer incidence in the United States.
  Medscape Oncology, May 09, 2022
• Statins for Kids: When to Pull the Trigger   The Cribsiders hit the highlights of expert recommendations for screening, diagnosis, and management of dyslipidemia in pediatric patients.
  The Cribsiders, May 05, 2022
• Hands-on for HF: New Considerations for Cardiac Rehab   Drs Daniel Forman and Gordon Reeves discuss how the REHAB-HF trial results inform potential new directions in exercise training for both HFpEF and HFrEF patients that may be beneficial.
  American College of Cardiology & Medscape , May 05, 2022
• Adieu, Interventional Cardiology: My Journey to a New Ikigai How do you know when it's time to let go of a career path that was your raison d'etre? Health problems set this cardiologist on a spiritual journey to find out.
  theheart.org on Medscape, May 05, 2022
• Therapies 'Not Used Enough' in Patients With T2D and CVD Risk   Dr Anne Peters discusses a paper demonstrating the low use of appropriate therapies in patients with type 2 diabetes and established cardiovascular risk.
  Medscape Diabetes & Endocrinology, May 04, 2022
• ACC 2022: Unmet Needs and Emerging Therapies in Lipid Management   Erin D. Michos, MD, reflects on ACC 2022 and the clinical implications of the APOLLO trial and the CANTOS study.
  Medscape, May 04, 2022